Antiphospholipid syndrome 2007. Current aspects of laboratory diagnostics and their therapeutic consequences;Antiphospholipid-syndrom 2007. Aktuelle aspekte in der labordiagnostik und deren therapeutische konsequenzen

Zeitschrift fur Rheumatologie

Volumn 66, Issue 3, 2007, Pages 198-205

  Schuchmann, S ^a,b   Dorner T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Anticardiolipin antibodies; Anticoagulation; Antiphospholipid antibodies; Lupus anticoagulant; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FETUS OUTCOME; HUMAN; MATERNAL CARE; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; GERMANY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 34250170805     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-007-0155-7     Document Type: Review

References (33)

1. Amengual O, Atsumi T, Khamashta MA et al. (1996) Specificity of ELISA for antibodies to beta 2-glucoprotein I in patients with antiphospholipid syndrome. Br J Rheumatology 35: 1239-1243
2. Amengual O, Atsumi T, Koike T (2004) Antithrombin antibodies and the diagnosis of antiphospholipid syndrome. Clin Immunol 112: 144-149
3. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151: 933-938
4. Bertolaccini ML, Khamashta MA, Hughes GRV (2005) Diagnosis of antiphospholipid syndrome. Nat Clin Practice 1: 40-46
5. Brey RL, Chapman J, Levine SR et al. (2003) Stroke and the antiphospholipid syndrome: consensus meeting in Taormina 2002. Lupus 12: 508-513
6. Cervera R, Piette JC, Font J et al., Euro-Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46: 1019-1027
7. Conley CL, Hartmann RC (1952) A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31: 621-622
8. Crowther MA, Ginsberg JS, Julian J et al. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349: 848-853
9. de Groot PG, Derksen RHWM (2005) Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 3: 1854-1860
10. Dörner T, Hoppe B, Salama A et al. (2005) Antibodies against protein Z and fetal loss: current perspectives. Clin Exp Med 5: 50-54
11. Feinstein DI, Rapaport SI (1972) Acquired inhibitors of blood coagulation. Prog Hemostasis Thromb 1: 75-95
12. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101: 1827-1832
13. Harris EN, Gharavi AE, Boey ML et al. (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic erythematosus. Lancet 2: 1211-1214
14. Harris EN, Pierangeli SS (2004) Primary, secondary, catastrophic antiphospholipid syndrome: is there a difference? Thromb Res 114: 357-361
15. Haserick JR, Long R (1952) Systemic lupus erythematosus preceded by false-positive serlogic test for syphilis: presentation of five cases. Ann Intern Med 37: 559-565
16. Khamashta MA, Cuadrado MJ, Mujic F et al. (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332: 993-997
17. Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospolipid antibody syndrome. JAMA 295: 1050-1057
18. Lockwood CJ, Romero R, Feinberg RF et al. (1989) The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 161: 369-373
19. Lutters BC, Derksen RH, Tekelenburg WL et al. (2003) Dimers of b2-glykoprotein I increase platelet deposition to collagen via interaction with phospholipids and apolipoprotein E receptor 2. J Biol Chem 278: 33831-33838
20. Mackworth-Young CG (2004) Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 136: 393-401
21. Matsuura E, Igarashi Y, Yasuda T et al. (1994) Anticardiolipin antibodies recognize beta 2-glucopretein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179: 457-462
22. Miyakis A, Lockshin MD, Atsumi T et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306
23. Ost D, Trepper J, Mihara H et al. (2005) Duration of anticoagulation following venous thromboembolism: a meta-analysis. JAMA 294: 706-715
24. Pangborn MC (1941) A new serologically active phopholipid from beef heart. Proc Soc Exp Biol Med 48: 484-486
25. Reber G, Schousboe I, Tincani A et al. (2002) Interlaboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 88: 66-73
26. Robertson B, Greaves M (2006) Antiphospholipid syndrome: an evolving story. Blood Rev 20: 201-212
27. Simantov R, LaSala JM, Lo SK et al. (1995) Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96: 2211-2219
28. Thiagarajan P, Sharpiro SS, De Marco L (1980) Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanisms of a lupus anticoagulant. J Clin Invest 66: 397-405
29. Wassermann A, Neisser A, Bruck C (1906) Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenschr 32: 745-746
30. Wilson WA, Gharavi AE, Koike T et al. (1999) International consensus statement on priliminary classification criteria for definite antiphospholipid syndrome. Arthritism Rheum 42: 1309-1311
31. Wisløff F, Jacobson EM, Liestøl S (2003) Laboratory diagnosis of the antiphospolipid syndrome. Thromb Res 108: 263-271
32. Wong RC, Gillis D, Adelstein S et al. (2004) Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 36: 63-68
33. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K (1995) Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 86: 555-559